Blood and marrow stem cells transplantation in multiple sclerosis. Present and future in its use and selection of patients

被引：0

作者：

Skromne Eisenberg, E. ^{[1
]}

Rivera Olmos, V. M. ^{[2
]}

Ordonez Boschetti, L. ^{[1
]}

Ontaneda Johnson, D. ^{[1
]}

机构：

[1] Baylor Coll Med, Invest Esclerosis Multiple, Houston, TX 77030 USA

[2] Methodist Hosp, Baylor Coll Med, Maxine Mesinger Multiple Sclerosis Clin, Neurol, Houston, TX USA

来源：

REVISTA MEXICANA DE NEUROCIENCIA | 2006年 / 7卷 / 02期

关键词：

Blood and marrow stem cells transplantation; multiple sclerosis;

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Multiple sclerosis (MS) is a disease with an autoinmune pathophysiology. A new and promising treatment in this group of patients is the blood and marrow stem cells transplant at ion which is currently an experimental treatment with evident immuno-suppressant effects. It has not been demonstrated any effect on neurodegeneration and it is preferred to use this procedure as a non-conventional treatment of multiple sclerosis. Select ion of patients should be strict, mainly in patients with moderate severity and an important inflammatory component. It is not a rescue treatment because its utility in progressive forms or advanced MS has not been demonstrated and the risk is high. This review includes an analysis of the current protocols and their results.

引用

页码：164 / 169

页数：6

共 50 条

[1] Transplantation of Stem Cell-derived Cells in a Model of Multiple Sclerosis.
Coleman, Ronald
IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2016, 52 : S4 - S5
[2] Allogeneic stem cell transplantation for chronic myelogenous leukemia in two patients with multiple sclerosis.
Hentschke, P
Fredrikson, S
Lönnqvist, B
Aschan, J
Ringden, O
Ljungman, P
BONE MARROW TRANSPLANTATION, 1999, 23 : S34 - S34
[3] The use of autologous haematopoietic stem cell transplantation as a first line disease modifying therapy in patients with 'aggressive' multiple sclerosis.
Das, J.
Snowden, J.
Burman, J.
Freedman, M.
Atkins, H.
Bowman, M.
Burt, R.
Sarccardi, R.
Innocenti, C.
Mistry, S.
Bell, S.
Ismail, A.
Jessop, H.
Sharrack, B.
MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 87 - 88
[4] Safety of autologous bone marrow mesenchymal stem cells intrathecal transplantation in patients with progressive multiple sclerosis
Swiderek-Matysiak, M.
Wojtkiewicz, J.
Habich, A.
Selmaj, I.
Maksymowicz, W.
Selmaj, K.
EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 715 - 715
[5] Effects of mesenchymal stem cells transplantation on multiple sclerosis patients
Barati, Shirin
Tahmasebi, Fatemeh
Faghihi, Faeze
NEUROPEPTIDES, 2020, 84
[6] Bone marrow and stem cell transplantation in multiple sclerosis?
Haase, CG
Hohlfeld, R
NERVENARZT, 1999, 70 (02): : 178 - 181
[7] Autologous non-myeloablative peripheral blood stem cell transplantation in patients with systemic sclerosis.
Barr, Walter G.
Oyama, Yu
Statkute, Laisvyde
Corbridge, Thomas
Yaung, Kimberly
Quigley, Kathleen
Verda, Larissa
Krosnjar, Nela
Bronesky, Delphine
Burt, Richard K.
ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S314 - S314
[8] Immunohistochemistry analysis of bone marrow biopsies in multiple sclerosis patients undergoing autologous haematopoietic stem cells transplantation
Carrai, Valentina
Donnini, Irene
Mazzanti, Benedetta
Alterini, Renato
Amato, Maria Pia
Barilaro, Alessandro
Bosi, Alberto
Massacesi, Luca
Portaccio, Emilio
Repice, Anna Maria
Rotunno, Giada
Saccardi, Riccardo
CLINICAL NEUROLOGY AND NEUROSURGERY, 2013, 115 (07) : 1044 - 1048
[9] Effectiveness of autologous bone marrow mesenchymal stem cells intrathecal transplantation in patients with secondary progressive multiple sclerosis
Swiderek-Matysiak, M.
Wojtkiewicz, J.
Habich, A.
Selmaj, I.
Maksymowicz, W.
Selmaj, K.
MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 678 - 678
[10] Selection of Patients With Multiple Sclerosis to Undergo Autologous Hematopoietic Stem Cell Transplantation
Racke, Michael K.
Imitola, Jaime
JAMA NEUROLOGY, 2017, 74 (04) : 392 - 394

← 1 2 3 4 5 →